Schedule of Pharmaceutical Benefits - 1 January 2024

1 January 2024 - The January 2024 issue of the Schedule of Pharmaceutical Benefits is out and now in effect. ...

Read more →

AstraZeneca cancer drug Calquence cost tumbles with PBS listing

23 December 2023 - An AstraZeneca drug’s listing on the PBS from January 1 will see bills fall massively for people ...

Read more →

Cheaper medicines for breast cancer, small cell lung cancer, biliary tract cancer, juvenile idiopathic arthritis and Crohn's disease

11 December 2023 - From 1 December 2023, Australians with small cell lung cancer, biliary tract cancer, juvenile idiopathic arthritis and ...

Read more →

Keytruda is a step closer to being available for more cancers listed on the PBS

1 December 2023 - Thousands of cancer patients in Australia will benefit from a major change that would see Keytruda offered ...

Read more →

Schedule of Pharmaceutical Benefits - 1 December 2023

1 December 2023 - The December 2023 issue of the Schedule of Pharmaceutical Benefits is out and now in effect. ...

Read more →

New Zealand Pharmaceutical Schedule - 1 December 2023

1 December 2023 - The December 2023 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...

Read more →

New treatment for advanced prostate cancer added to the PBS

16 November 2023 - Prostate cancer is one of the most commonly diagnosed cancer in Australia. ...

Read more →

New treatment for women battling aggressive breast cancer

6 November 2023 - Women diagnosed with an aggressive form of breast cancer will have access to new treatment through the ...

Read more →

Schedule of Pharmaceutical Benefits - 1 November 2023

1 November 2023 - The November 2023 issue of the Schedule of Pharmaceutical Benefits is out and now in effect. ...

Read more →

New Zealand Pharmaceutical Schedule - 1 November 2023

1 November 2023 - The November 2023 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...

Read more →

PBS listing expanded to include treatment resistant high frequency episodic migraine

31 October 2023 - From 1 November 2023, Australians with treatment resistant high frequency episodic migraine will have access to fremanezumab ...

Read more →

Expanded access to chronic heart failure treatment on the PBS

30 October 2023 - More Australians with chronic heart failure will have access to subsidised treatment under the PBS. ...

Read more →

100,000 patients eligible for heart drug under PBS

28 October 2023 - Almost 100,000 patients are set to save hundreds of dollars per year as access to a ...

Read more →

Cheaper medicines for cervical cancer, urotherial cancer and spinal muscular atrophy

16 October 2023 - From 1 October 2023, Australians with cervical cancer, urothelial cancer and spinal muscular atrophy will have access ...

Read more →

New Zealand Pharmaceutical Schedule - 1 October 2023

1 October 2023 - The October 2023 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...

Read more →